DIRS.INFO The most relevant business & tech news

☆ Troubled health name bounces after strong quarter and guidance. Here's our view on the stock
▼ + stars: | 2023-08-03 | by ( Zev Fima | ) www.cnbc.com time to read: +6 min

Another possible catalyst is the monetization of BHC's Bausch + Lomb (BLCO) stake. Bausch + Lomb update On the earnings release, management highlighted a change in thinking about how to handle their stake in Bausch + Lomb. We'll be on the lookout for more information on the Bausch + Lomb situation in the coming days. Guidance BHC management raised their full-year revenue guidance for 2023 while reaffirming their adjusted EBITDA outlook. Excluding Bausch + Lomb, the team now expects full-year revenue to be in the range of $4.5 billion to $4.65 billion.

Persons: it's, Refinitiv, BHC's Bausch, Bausch, We'll, Generics, Jim Cramer's, Jim Cramer, Jim, Rafael Henrique Organizations: Health, Bausch Health, Management, Bausch Health Companies, BHC's, Dentistry, CNBC Locations: BHC, Bausch, East, Africa, Canada, Asia, China

☆ On tap this week: Jobs report plus 10 key earnings. Here's what we want to see
▼ + stars: | 2023-07-29 | by ( Zev Fima | ) www.cnbc.com time to read: +18 min

All three major averages advanced for the week, powered by strong mega-cap earnings and favorable inflation data. Looking to next week, earnings season enters its second half with the last of our mega-caps — Apple (AAPL) and Amazon (AMZN) — set to report on Thursday. We'll get a better read on the employment picture on Wednesday with the ADP report and then, more importantly, on Friday's nonfarm payrolls report for July. Thursday after the close brings us to the main events of the week: Earnings from Apple and Amazon. For those looking to review first quarter performance ahead of these releases, be sure to keep our first-quarter earnings report card handy.

Persons: We'll, that's, Stanley Black, Decker, Emerson, Bausch, Leggett, Platt, SIRI, Ares, COLM, PERI, Kraft Heinz, Phillips, Ferrari N.V, Johnson, Robinson, COOK, BUD, Kellogg, Papa, Pitney Bowes, Parker, Trimble, Ziff Davis, Nonfarm, Jim Cramer's, Jim Cramer, Jim, Apple Tim Cook, Kevin Dietsch Organizations: Nasdaq, Dow, Federal Reserve, Federal, ISM Manufacturing, Services PMI, Investors, Caterpillar, Devices, Starbucks, Natural Resources, AMD, Management, Emerson Electric and, Humana, Bausch Health, Apple, Microsoft, Resource Partners, AerCap Holdings, CNA Financial Corp, CNA, Apellis Pharmaceuticals, Bank, SJW, Hutchison China MediTech, Camtek Ltd, Silvercrest Asset Management, Loews Corp, Oxford Lane Capital Corp, Banco Santander, Silicom Ltd, SuperCom Ltd, Arista Networks, Avis Budget Group, Diamondback Energy, Lattice Semiconductor Corp, Republic Services, Yum China Holdings, Western Digital Corp, Power Systems, Tenet Healthcare Corp, Vornado Realty, BioMarin Pharmaceutical, PetMed, SBA Communications Corporation, Brixmor, Snack Foods Corp, Cushman & Wakefield, Sanmina Corporation, TFI, PMI, Cruise Line Holdings Ltd, Uber Technologies, Pfizer, Enterprise Products Partners, Merck, JetBlue Airways Corporation, Allegro MicroSystems, Altria, SunPower Corp, SiriusXM Holdings, Molson Coors Beverage, Marriott International, Toyota Motor Corp, BP, SYSCO Corp, Marathon Petroleum Corp, Ares Management, Equitrans Midstream Corporation, Game Technology, Illinois Tool, IDEXX Laboratories, Rockwell Automation, Packaging International Corp, Gartner, Zebra Technologies Corp, IQVIA Holdings, Oshkosh Corporation, Leidos Holdings, Eaton Corp, yte Corp, Lear Corp, Starbucks Corp, Devon Energy Corp, SolarEdge Technologies, Lumen Technologies, Virgin Galactic Holdings, Caesars Entertainment, VF Corp, Sciences Corp, Paycom, Vertex Pharmaceuticals, Suncor Energy, Holdings, Chesapeake Energy Corp, Boston Properties, American International Group, AIG, Allstate Corp, Aspen Technology, Electronic Arts, EA, Flowserve Corporation, Denny's, Corp, Prudential Financial, Store, Ternium S.A, Vimeo, Emerson, Lomb, CVS Health, Generac Holdings, Cameco Corp, Perion Network Ltd, Builders, Carlyle Group, Scorpio, Teva Pharmaceutical Industries, Ltd, Rithm Capital Corp, AeroSystems Holdings, Vertiv Holdings Co, Johnson Controls, CDW Corp, DuPont, Brands Holdings, Scotts Miracle, Gro, SMG, Brands, Allegheny Technologies, AmerisourceBergen Corporation, ABC, Real Estate Corporation, Adient plc, Editas, Garmin Ltd, WWE, Bunge Ltd, Criteo S.A, PayPal, QUALCOMM, Occidental Petroleum Corp, Apache Corp, Albemarle Corp, MGM Resorts International, MGM, Marathon Oil Corp, Joby Aviation, Industrial, CF Industries Holdings, Goodyear Tire &, Realty ome Corp, Metlife, Pacific Biosciences of, Rush Street Interactive, Zillow, JFrog Ltd, Herbalife Nutrition Ltd, Simon Property Group, McKesson Corp, Storage, Cerus Corporation, GXO Logistics, MAX Holdings, Health, Anheuser, Busch InBev, Warner Bros ., Cheniere Energy, ConocoPhillips, Hasbro, CIGNA Corp, Lantheus Holdings, Regeneron Pharmaceuticals, Fiverr International, Air Products & Chemicals, TopBuild Corp, EPAM Systems, Lightspeed Commerce, Aurinia Pharmaceuticals, Cummins, CMI, Slair Corporation, Starwood Property Trust, Vulcan, Alnylam Pharmaceuticals, New Energy Corp, Cedar Fair Entertainment, Intellia Therapeutics, Lending, Privia Health, Dickinson, Chimera Investment, CIM, Hyatt Hotels Corp, Lion Electric, LEV, Deluxe Corp, Murphy Oil Corp, PBF Energy, Papa John's, Targa Resources Corp, Wix.com Ltd, Apollo Global Management, LLC, Butterfly, Sempra Energy, Aptiv PLC, Brookfield Infrastructure Partners, Canada Goose Holdings, Hannifin Corporation, WESCO International, WCC, Arrow Electronics, Constellation Energy Group, Midstream Partners, Coinbase, Petroleo Brasileiro SA Petrobras, Gilead Sciences, Opendoor Technologies, Booking Holdings, Atlassian Corporation, International, Redfin Corporation, Motorola Solutions, Monster Beverage Corporation, Consolidated Edison, Rocket Companies, Apple Hospitality, Cirrus, Resources, Universal Display Corporation, Chesapeake Utilities Corp, Social, Defense, Security Solutions, Post Holdings, Tandem Diabetes Care, Nikola Corporation, Magna International, Dominion Energy, ACM Research, Frontier Communications, Brookfield Renewable Partners, inTEST Corporation, American Pipeline, TELUS International, XPO Logistics, Fluor Corp, Gray Television, Cboe, LyondellBasell Industries, Twist Bioscience, Global, Jim Cramer's Charitable, CNBC, Allen & Company Sun Valley, Getty Locations: U.S, China, India, Oxford, Chile, Illinois, Columbia, Pacific, Pacific Biosciences of California, Southern, PBI, Gilead, Sun Valley , Idaho

☆ AI-Targeted Internet Advertisements Fueling Looming Addiction Crisis
▼ + stars: | 2023-07-13 | by ( Albert Fox Cahn | ) www.businessinsider.com time to read: +13 min

A new breed of direct-to-consumer services is aggressively using targeted ads to sell habit-forming medications. In short, AI and surveillance capitalism, which empower today's targeted ads, have joined forces with the deadly OxyContin playbook. As the Journal reported, after ADHD medications grew to 20% of the VC-funded company's business, driving a $4.8 billion valuation, things came crashing to earth. We as a society may have come to accept being stalked by targeted ads, but consequences are much graver when the product itself is a danger. But above all, we need rules that ban targeted ads for drugs that can get patients hooked.

Persons: Taylor Swift, they're, haven't, Van Zee, OxyContin, prescribers, Dr, David Sack, Anthony Yeung, recreationally, Yann Poncin, shih, Ryan Haight, Ryan Haight Act's, Albert Fox Cahn Organizations: Circle, Purdue, American, of Public Health, Sackler family's pharma, Physicians, Yale School of Medicine, Bloomberg, Drug Enforcement Agency, Department of Health, Human Services, Ryan, Twitter, FDA Locations: Canadian, California, United States, New Zealand, New York

☆ Healthcare VCs are focusing their bets on a handful of top startups, forcing the rest to scramble to stay afloat
▼ + stars: | 2023-07-10 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +6 min

In the first half of 2023, healthcare investors have written big checks for their top startup picks. 2023 is on track to be the lowest year of healthcare funding since 2019, Rock Health says. Digital-health startups in the US raised $6.1 billion in the first half of 2023, Rock Health's H1 2023 funding report published on Monday found. Right now, 2023 is on track to be the lowest healthcare funding year since 2019, according to Rock Health. Krasniansky said Rock Health expects many of the impending shutdowns to impact healthcare startups that sell products and services to patients online and on-demand, especially direct-to-consumer companies like telemedicine or mail-order-pharmacy startups.

Persons: It's, haven't, Healthcare's, healthcare's, Adriana Krasniansky, Krasniansky, Ian Chiang, he's, Lynne Chou O'Keefe, it's, Corey McCann, Chou O'Keefe, — Organizations: Rock Health, megadeals, Monogram Health, Frist Cressey Ventures, Flare Capital Partners, Define Ventures, Pear, Madison, Pear Therapeutics

☆ Bausch + Lomb expands eye-care portfolio with J&J's Blink
▼ + stars: | 2023-07-06 | by ( ) www.reuters.com time to read: +1 min

July 6 (Reuters) - Bausch + Lomb (BLCO.TO) acquired Johnson & Johnson's (JNJ.N) eye and contact lens drops brand Blink for $106.5 million, marking its second deal in two weeks to bolster the contact lens maker's portfolio of eye care products. J&J's Blink portfolio of over-the-counter drugs include several eye drops and contact lens rewetting drops that are used to relieve dry eye symptoms, Bausch + Lomb said on Thursday. Last week, Bausch + Lomb struck a $1.75 billion deal with Swiss drugmaker Novartis (NOVN.S) to buy several eye-care products, including anti-inflammation eye drop Xiidra. The company is in the process of being spun out from Bausch Health Companies (BHC.TO). The global dry eye disease market is expected to be worth around $5 billion, according to Morningstar analyst Keonhee Kim.

Persons: Johnson, Bausch, Lomb, Keonhee Kim, Mariam Sunny, Savio D'Souza, Shinjini Organizations: Swiss, Novartis, Bausch Health, U.S . Food, Drug Administration, Thomson Locations: U.S, United States, Bengaluru

☆ A $7 billion startup wanted to build patient-friendly healthcare. Its bet on buzzy weight-loss drugs is testing that vision.
▼ + stars: | 2023-06-29 | by ( Blake Dodge | Rebecca Torrence | ) www.businessinsider.com time to read: +12 min

Patient complaints go beyond the Wegovy shortageKaitlyn's complaints echo an array of issues faced by other Ro patients seeking weight-loss drugs. The patients Insider interviewed asked to be identified by their first names to protect their privacy. In this chat log, a Ro weight-loss patient sends messages to the startup asking to cancel the program. Reitano told Insider that around 90% of Ro patients got a response within 24 hours. "Until these DTC companies generally start getting into the muck of healthcare, they're not going to have a material impact," Parker told Insider.

Persons: Ro, Zachariah Reitano, Reitano, Li Ran, Robyn Phelps, Kaitlyn, She'd, didn't, she's, couldn't, Max Kerwick, drugstores, Max, Ro's, aren't, hasn't, Florian Gaertner, it's, TJ Parker, they're, Parker Organizations: New York, Getty, Better Business Bureau, Nordisk, Better Business, CareMetx, Ro, TechCrunch Locations: Xinhua, New York, New York City

☆ Here are Friday's biggest analyst calls: SoFi Technologies, AutoZone, Nvidia, Meta and more
▼ + stars: | 2023-06-16 | by ( Sarah Min | ) www.cnbc.com time to read: +6 min

Bank of America downgrades SoFi Technologies to neutral from buy The downgrade follows SoFi' s recent rally. Our C$51 Price Target is 39% above the current stock price and we see close to 3:1 upside/downside skew." UBS upgrades AutoZone to buy from neutral Analyst Michael Lasser raised the price target to $2,900 from $2,800. Wells Fargo initiates Neogen Corporation at overweight and $22 price target Wells Fargo said it liked the company's improving margins. Wells Fargo initiates Bio-Rad Laboratories Inc. at overweight and $550 price target Wells said Bio-Rad's valuation is attractive at current levels.

Persons: Jefferies, John Hecht, LendingClub, Morgan Stanley, Mauricio Serna, Aritzia, Michael Lasser, Carvana, it's, Wells, Ph3, Wells Fargo, Piper Sandler, TD Cowen downgrades, LOE, Michael Bloom Organizations: . Bank of America, Technologies, Nvidia, Bank of America, UBS, West Pharmaceutical Services, Stevanato, MorphoSys, Neogen, Rad Laboratories Inc, SoFi Technologies, Health Companies Locations: EBITDA, 4Q23, BLCO

☆ The CEO of pharma giant Eli Lilly shares 3 ways AI could transform his industry
▼ + stars: | 2023-06-15 | by ( Yeji Jesse Lee | ) www.businessinsider.com time to read: +5 min

The CEO of Eli Lilly said he expects AI to massively change the productivity of the workplace. According to David Ricks, the CEO of the pharma giant Eli Lilly, the technology has the potential to upend the industry. Ricks told Insider that AI is "one of the most exciting technological moves" he's seen in a long time. Three ways Lilly wants to use AIRicks said he sees three main ways Lilly and the larger biopharma space could use AI. In May, Lilly announced a $250 million partnership with pharmaceutical-technology company XtalPi to uncover new potential drugs using AI.

Persons: Eli Lilly, David Ricks, Ricks, It's, Lilly Organizations: Biotech, pharma, Morning

☆ The 3 main ways digital-health startups are competing for a slice of the $13 billion market for obesity care
▼ + stars: | 2023-05-24 | by ( Yeji Jesse Lee | ) www.businessinsider.com time to read: +4 min

Weight-loss drugs like Ozempic and Wegovy have surged in popularity. A Rock Health report lays out three main ways startups are competing for a slice of the market. As weight-loss drugs like Ozempic and Wegovy surge in popularity, digital-health startups are jumping in — offering everything from prescriptions to weight-management tools to compete for a slice of the $13 billion market. That's according to a new report by Rock Health, which lays out three main ways digital-health companies are vying to get in on obesity care. Rock Health said these platforms could be used in conjunction with weight-loss drugs to help track progress.

☆ The CEO of virtual-care veteran Omada shares why he's avoiding the race to prescribe trendy new weight-loss drugs and what he's doing instead
▼ + stars: | 2023-05-17 | by ( Blake Dodge | ) www.businessinsider.com time to read: +5 min

Omada Health, a leader in managing diabetes, is grappling with how it can play a role. Health companies are at a crossroads in deciding how to respond to the frenzy for prescription weight-loss drugs such as Ozempic and Wegovy. Now, as the rise of these powerful drugs upends the weight-loss industry, Omada is grappling with how it can play a role. Instead of prescribing the drugs, Omada is pitching itself as a gatekeeper, akin to the role health insurers usually play. One survey from 2022 found that only about a fifth of companies cover weight-loss drugs for their workers.

☆ The pharmacy that quietly powered top startups in the hottest part of healthcare is trying to reinvent itself after losing customers and closing facilities
▼ + stars: | 2023-05-15 | by ( Rebecca Torrence | Blake Dodge | ) www.businessinsider.com time to read: +10 min

"We were shocked," a former employee in Truepill's business development division said of the layoffs. Insider spoke with five former and two current Truepill employees about the challenges the company is confronting after a tumultuous year. Truepill was hiring employees rapidly, accumulating about 1,800 employees by the spring of 2022, according to one former employee in Truepill's business division. Since then, there's been a companywide push to inch closer to profitability, one of the current employees told Insider. It's also downsizing its Miami pharmacy, the current employee said.

☆ How big companies are contending with a frenzy of demand for Ozempic from their workers
▼ + stars: | 2023-05-10 | by ( ) www.businessinsider.com time to read: +5 min

Demand for expensive weight-loss drugs such as Ozempic and Wegovy is soaring. Companies that foot the bill for their workers' health coverage are mulling whether to pay for them. Across the US, companies are facing a critical decision: whether to foot the bill for the expensive weight-loss drugs that have exploded in popularity in recent months. Andrews estimated that more than half the companies in the alliance covered weight-loss drugs. Andrews' comments offer a window into how big US companies are grappling with the rising demand for and high costs of weight-loss treatment.

The digital-health sector in 2020 and 2021 was the hottest part of healthcare. We spoke with top bankers and dealmakers to understand what comes next as the market cools. The pace of digital-health deals has generally slowed since the highs of 2021. Founders can thank rising interest rates, a punishing stock market for digital-health companies, and a minor banking crisis to name just a few reasons for that. Here are the healthcare industry's go-to investment bankers, in alphabetical order, and their predictions for which trends may push digital-health deals forward after a funding slump.

☆ Bausch Health's quarter disappoints, guidance beats. But uncertainty prevails over patent litigation
▼ + stars: | 2023-05-04 | by ( Zev Fima | ) www.cnbc.com time to read: +5 min

Xifaxan sales were also up 7%. Internationally, reported Q1 sales of $247 million missed estimates but grew 1% compared to the year-ago period. Organic sales grew 5%, driven by strength in Canada and Europe. Organic sales grew 6%. Excluding Bausch + Lomb, the team reiterated their revenue guidance of $4.45 billion to $4.6 billion, as well as their adjusted EBITDA guidance of $2.3 billion to $2.4 billion.

☆ TikTok is looking more and more like a record label. It’s annoyed many in the music industry.
▼ + stars: | 2023-04-21 | by ( Diamond Naga Siu | ) www.businessinsider.com time to read: +4 min

Allbirds is one of the brands I'm looking at. TikTok is looking more and more like a record label. When TikTok launched SoundOn, a song-distribution and artist-services platform, some in the industry wondered whether it was trying to muscle its way into record labels' territory. TikTok is now looking to hire people who will "identify, sign, and develop new artists" as well as "design live show and merchandise strategies for artists globally." Get a front-row seat to TikTok's transformation into a record label here.

☆ The creepy secret behind online therapy
▼ + stars: | 2023-04-20 | by ( Tanmoy Goswami | ) www.businessinsider.com time to read: +16 min

Crisis Text Line, now in its 10th year of operations, uses artificial intelligence to respond to people experiencing emotional abuse, self-harm, and suicidal thoughts. 'The vast majority of mental-health apps are exceptionally creepy'BetterHelp, a poster child of online therapy founded in 2013, calls itself "the world's largest therapy platform" and says it has over 2 million users. One of the first popular mental-health apps, PTSD Coach, was launched by the US Department of Veteran Affairs in 2011. But for mental-health companies these practices can undermine the very foundations of mental-health care: dignity, trust, and psychological safety. As Crisis Text Line wrote on its website extolling its deal with Loris: "Why sell T-shirts when you can sell what your organization does best?"

☆ Johnson & Johnson (JNJ) earnings Q1 2023
▼ + stars: | 2023-04-18 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +5 min

Johnson & Johnson shares fell Tuesday after the company reported adjusted earnings and revenue that topped Wall Street's expectations, but lowered its sales guidance for its pharmaceutical business. J&J is now forecasting 2023 sales of $97.9 billion to $98.9 billion, about $1 billion higher than the guidance provided in January. Lawsuits allege the company's talc products were contaminated with the carcinogen asbestos, which caused ovarian cancer in thousands of individuals. Some suits link several deaths to J&J's talc products. Read the full J&J earnings report.

☆ 6 startups that have raised $100 million or more in 2023 to change healthcare
▼ + stars: | 2023-04-11 | by ( Yeji Jesse Lee | ) www.businessinsider.com time to read: +3 min

The healthcare-staffing startup ShiftKey raised $300 million in a round led by its majority investor Lorient Capital. The clinical-trials-tech startup Paradigm raised a $203 million Series A round led by Arch Venture Partners and General Catalyst. The healthcare-staffing startup ShiftMed raised a $200 million round led by Panoramic Ventures. raised a $200 million round led by Panoramic Ventures. Vytalize Health, a startup that helps doctors provide value-based care, raised $100 million from Enhanced Healthcare Partners, Monroe Capital, and North Coast Ventures.

☆ See the 6 startups that have raised the most cash in 2023 to transform healthcare
▼ + stars: | 2023-04-05 | by ( Yeji Jesse Lee | ) www.businessinsider.com time to read: +3 min

Startups in the industry raised $3.4 billion across 132 deals in the first three months of 2023. The healthcare-staffing startup ShiftKey raised $300 million in a round led by its majority investor Lorient Capital. The clinical-trials-tech startup Paradigm raised a $203 million Series A round led by Arch Venture Partners and General Catalyst. The healthcare-staffing startup ShiftMed raised a $200 million round led by Panoramic Ventures. raised a $200 million round led by Panoramic Ventures.

☆ Telemedicine Startups Wary of Regulatory Shift in War on Opioid Addiction
▼ + stars: | 2023-03-30 | by ( Brian Gormley | ) www.wsj.com time to read: 1 min

Telemedicine companies are facing a regulatory shift that many entrepreneurs say would undercut their ability to quickly prescribe medication that helps prevent opioid overdoses. During the Covid-19 pandemic, telehealth companies benefited from a waiver of the requirement that patients be seen in-person before receiving a telemedicine prescription for buprenorphine, a controlled substance used to treat opioid addiction.

☆ Telehealth Apps Sharing Consumer Data Draw FTC Crackdown
▼ + stars: | 2023-03-26 | by ( Patience Haggin | ) www.wsj.com time to read: 1 min

The Federal Trade Commission is expected to look at more apps as it focuses on health data. The Federal Trade Commission is cracking down on the data-sharing practices of telehealth companies, focusing on widespread uses of data that many companies in the industry have failed to disclose to users. The FTC earlier this month reached a proposed settlement with BetterHelp, a subsidiary of Teladoc Health Inc., over allegations that the therapy-focused telemedicine company promised to keep users’ health data private but shared it with advertising partners.

☆ Americans desperate for the hot weight-loss drug Ozempic are turning to Canada and Mexico because they can't afford it at home
▼ + stars: | 2023-03-20 | by ( ) www.businessinsider.com time to read: +12 min

She found CanShipMeds.com, one of many websites that says it ships a similar drug, Ozempic, from Canada at a lower cost. Delp is hardly the only American searching for weight-loss drugs across the border in Canada or Mexico. Medicare, the federal program that provides health coverage for people 65 and older, doesn't cover weight-loss drugs at all, though there's a push to change that. People are looking to Canada and Mexico for cheaper OzempicCrystal Cox/Business InsiderUntil insurance coverage improves, people will look abroad to afford the weight-loss drugs. Want to tell us about your experience with weight-loss drugs like Ozempic and Mounjaro?

☆ Here’s our fourth-quarter earnings report card for all the stocks in our portfolio
▼ + stars: | 2023-03-10 | by ( Zev Fima | ) www.cnbc.com time to read: +20 min

Fourth-quarter earnings season is in the rearview mirror and most Club stocks reported results ahead of, or in line with, analysts' forecasts. Moreover, excluding foreign exchange fluctuations, this marked the ninth quarter in a row of 20% or better annual earnings growth. Nvidia (NVDA) reported a very strong quarter and better-than-expected guidance for the current quarter . Eli Lilly 's (LLY) fourth-quarter results came up a bit short on revenue but delivered a strong bottom line. Despite missing on top-line expectations, Wells Fargo 's (WFC) earnings came in better-than-expected, as the bank realized the benefits of higher interest rates .

☆ Noom quietly started writing prescriptions for trendy new weight-loss drugs
▼ + stars: | 2023-03-07 | by ( ) www.businessinsider.com time to read: +4 min

The popular weight-loss app Noom quietly launched a new program that offers some users access to prescription anti-obesity medications. Called Noom Clinical, the program is meant to "build additional support" for app users, a company spokesperson said in a statement to Insider. Startups like Noom want to capitalize on a surge in demand for new weight-loss drugsSaeju Jeong, Co-founder & CEO, Noom Piaras Ó Mídheach/Sportsfile for Web Summit via Getty Images)Noom's foray into prescribing medication comes as demand for weight-loss drugs surges. NoomNoom, which introduced its weight loss app in 2017, is backed by venture firm Oak HC/FT and private-equity giant Silver Lake. According to the spokesperson, Noom began rolling out the new prescription-drug program to a small number of users in the fall.

☆ Here's an exclusive look at the pitch deck that Y Combinator alum Opkit, a health insurance verification startup, used to raise funding from investors like Plaid CEO Zach Perret's VC firm
▼ + stars: | 2023-03-07 | by ( Madeline Renbarger | ) www.businessinsider.com time to read: +3 min

Opkit is a startup that helps telehealth companies verify and process patient health insurance. Software engineers Sherwood Callaway and Justin Ko first met as early employees at the fintech startup Brex and became fast friends. As more telehealth companies were popping up after the pandemic, they often had issues with quickly processing patient health insurance for care, Callaway told Insider. Opkit also offers providers an insurance dashboard, that allows telehealth employees to perform eligibility checks or inquiries to insurance companies about specific patients' plans. "Opkit was our first experience doing venture fundraising, and Y Combinator really helped us make connections with investors," said Callaway.

Search resuls for: "Health Companies"

25 mentions found